107 related articles for article (PubMed ID: 35139586)
21. Do Patients After Chondrosarcoma Treatment Have Age-appropriate Bone Mineral Density in the Long Term?
Hobusch GM; Tiefenboeck TM; Patsch J; Krall C; Holzer G
Clin Orthop Relat Res; 2016 Jun; 474(6):1508-15. PubMed ID: 26883654
[TBL] [Abstract][Full Text] [Related]
22. Can a Nomogram Help to Predict the Overall and Cancer-specific Survival of Patients With Chondrosarcoma?
Song K; Shi X; Wang H; Zou F; Lu F; Ma X; Xia X; Jiang J
Clin Orthop Relat Res; 2018 May; 476(5):987-996. PubMed ID: 29470233
[TBL] [Abstract][Full Text] [Related]
23. Treatment method and prognostic factors of chondrosarcoma: based on Surveillance, Epidemiology, and End Results (SEER) database.
Hua KC; Hu YC
Transl Cancer Res; 2020 Jul; 9(7):4250-4266. PubMed ID: 35117792
[TBL] [Abstract][Full Text] [Related]
24. Conditional Survival Analysis for Spinal Chondrosarcoma Patients After Surgical Resection.
Song K; Lin K; Guan H; Li F
Spine (Phila Pa 1976); 2020 Aug; 45(16):1110-1117. PubMed ID: 32205690
[TBL] [Abstract][Full Text] [Related]
25. Survival and prognostic factors in conventional central chondrosarcoma.
Fromm J; Klein A; Baur-Melnyk A; Knösel T; Lindner L; Birkenmaier C; Roeder F; Jansson V; Dürr HR
BMC Cancer; 2018 Aug; 18(1):849. PubMed ID: 30143018
[TBL] [Abstract][Full Text] [Related]
26. Sixty percent 10-year survival of patients with chondrosarcoma after local recurrence.
Lin PP; Alfawareh MD; Takeuchi A; Moon BS; Lewis VO
Clin Orthop Relat Res; 2012 Mar; 470(3):670-6. PubMed ID: 21918803
[TBL] [Abstract][Full Text] [Related]
27. Oncologic impact of the curettage of grade 2 central chondrosarcoma of the extremity.
Cho WH; Song WS; Jeon DG; Kong CB; Koh JS; Kim JI; Lee SY
Ann Surg Oncol; 2011 Dec; 18(13):3755-61. PubMed ID: 21611858
[TBL] [Abstract][Full Text] [Related]
28. Chondrosarcoma in the United States (1973 to 2003): an analysis of 2890 cases from the SEER database.
Giuffrida AY; Burgueno JE; Koniaris LG; Gutierrez JC; Duncan R; Scully SP
J Bone Joint Surg Am; 2009 May; 91(5):1063-72. PubMed ID: 19411454
[TBL] [Abstract][Full Text] [Related]
29. [Clinical analysis of sinonasal chondrosarcoma in 47 cases].
Li WP; Lu HY; Wang H; Zhang HK; Liu Q; Sun XC; Hu L; Wang DH
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Jan; 55(1):14-20. PubMed ID: 31954383
[No Abstract] [Full Text] [Related]
30. The clinical pathological significance of FRAT1 and ROR2 expression in cartilage tumors.
He L; Yang Z; Zhou J; Wang W
Clin Transl Oncol; 2015 Jun; 17(6):438-45. PubMed ID: 25387569
[TBL] [Abstract][Full Text] [Related]
31. Primary Tumor Resection Prolongs Survival in Spinal Chondrosarcoma Patients With Distant Metastasis.
Song K; Lin K; Kang H; Dong Y; Guan H; Li F
Spine (Phila Pa 1976); 2020 Dec; 45(24):E1661-E1668. PubMed ID: 32925686
[TBL] [Abstract][Full Text] [Related]
32. Metastatic Potential of Grade I Chondrosarcoma of Bone: Results of a Multi-institutional Study.
Andreou D; Gilg MM; Gosheger G; Werner M; Hardes J; Pink D; Leithner A; Tunn PU; Streitbürger A
Ann Surg Oncol; 2016 Jan; 23(1):120-5. PubMed ID: 26350369
[TBL] [Abstract][Full Text] [Related]
33. The 'other' bone sarcomas in Japan: a retrospective study of primary bone sarcomas other than osteosarcoma, Ewing sarcoma and chondrosarcoma, using data from the Bone Tumuor Registry in Japan.
Nagano A; Tsugita M; Nishimoto Y; Akiyama H; Kawai A
Jpn J Clin Oncol; 2021 Aug; 51(9):1430-1436. PubMed ID: 34105731
[TBL] [Abstract][Full Text] [Related]
34. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.
Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ
J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634
[TBL] [Abstract][Full Text] [Related]
35. Chondrosarcoma of the phalanx: a locally aggressive lesion with minimal metastatic potential: a report of 35 cases and a review of the literature.
Bovée JV; van der Heul RO; Taminiau AH; Hogendoorn PC
Cancer; 1999 Nov; 86(9):1724-32. PubMed ID: 10547545
[TBL] [Abstract][Full Text] [Related]
36. Correlation between survival and tumour characteristics in patients with chondrosarcoma.
Kamal AF; Husodo K; Prabowo Y; Hutagalung EU
J Orthop Surg (Hong Kong); 2015 Dec; 23(3):365-9. PubMed ID: 26715720
[TBL] [Abstract][Full Text] [Related]
37. Survival and Prognosis of Chondrosarcoma Subtypes: SEER Database Analysis.
Amer KM; Munn M; Congiusta D; Abraham JA; Basu Mallick A
J Orthop Res; 2020 Feb; 38(2):311-319. PubMed ID: 31498474
[TBL] [Abstract][Full Text] [Related]
38. Mesenchymal chondrosarcoma: imaging features and clinical findings.
Ghafoor S; Hameed MR; Tap WD; Hwang S
Skeletal Radiol; 2021 Feb; 50(2):333-341. PubMed ID: 32734374
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of factors affecting survival rate in primary bone sarcomas with extremity and pelvis involvement.
Sofulu Ö; Erol B
Acta Orthop Traumatol Turc; 2020 May; 54(3):234-244. PubMed ID: 32544060
[TBL] [Abstract][Full Text] [Related]
40. Chondrosarcoma of bone: an assessment of outcome.
Lee FY; Mankin HJ; Fondren G; Gebhardt MC; Springfield DS; Rosenberg AE; Jennings LC
J Bone Joint Surg Am; 1999 Mar; 81(3):326-38. PubMed ID: 10199270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
